SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Identification of Streptococcus pneumoniae by a real-time PCR assay targeting SP2020.

Tavares, DA; Handem, S; Carvalho, RJ; Paulo, AC; de Lencastre, H; Hinds, J; Sá-Leão, R (2019) Identification of Streptococcus pneumoniae by a real-time PCR assay targeting SP2020. Sci Rep, 9 (1). p. 3285. ISSN 2045-2322 https://doi.org/10.1038/s41598-019-39791-1
SGUL Authors: Hinds, Jason

[img]
Preview
PDF Published Version
Available under License Creative Commons Attribution.

Download (1MB) | Preview

Abstract

Real-time PCR targeting lytA (the major autolysin gene) and piaB (permease gene of the pia ABC transporter) are currently used as the gold-standard culture-independent assays for Streptococcus pneumoniae identification. We evaluated the performance of a new real-time PCR assay - targeting SP2020 (putative transcriptional regulator gene) - and compared its performance with the assays previously described. A collection of 150 pneumococci, 433 non-pneumococci and 240 polymicrobial samples (obtained from nasopharynx, oropharynx, and saliva; 80 from each site) was tested. SP2020 and lytA-CDC assays had the best performance (sensitivity of 100% for each compared to 95.3% for piaB). The specificity for lytA and piaB was 99.5% and for SP2020 was 99.8%. Misidentifications occurred for the three genes: lytA, piaB and SP2020 were found in non-pneumococcal strains; piaB was absent in some pneumococci including a serotype 6B strain. Combining lytA and SP2020 assays resulted in no misidentifications. Most polymicrobial samples (88.8%) yielded concordant results for the three molecular targets. The remaining samples seemed to contain non-typeable pneumococci (0.8%), and non-pneumococci positive for lytA (1.7%) or SP2020 (8.7%). We propose that combined detection of both lytA-CDC and SP2020 is a powerful strategy for the identification of pneumococcus either in pure cultures or in polymicrobial samples.

Item Type: Article
Additional Information: Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. © The Author(s) 2019
SGUL Research Institute / Research Centre: Academic Structure > Infection and Immunity Research Institute (INII)
Journal or Publication Title: Sci Rep
ISSN: 2045-2322
Language: eng
Dates:
DateEvent
1 March 2019Published
21 January 2019Accepted
Publisher License: Creative Commons: Attribution 4.0
Projects:
Project IDFunderFunder ID
LISBOA-01-0145-FEDERFEDERUNSPECIFIED
LISBOA-01-0145-FEDER-016417Fundos Europeus Estruturais e de InvestimentoUNSPECIFIED
SFRH/BD/70147/2010Fundação para a Ciência e a TecnologiaUNSPECIFIED
PD/BD/128365/2017Fundação para a Ciência e a TecnologiaUNSPECIFIED
SFRH/BPD/99638/2014Fundação para a Ciência e a TecnologiaUNSPECIFIED
PubMed ID: 30824850
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/110747
Publisher's version: https://doi.org/10.1038/s41598-019-39791-1

Actions (login required)

Edit Item Edit Item